Premenstrual dysphoric disorder

Definition

PMDD is a diagnosable depressive disorder defined by a clear, repeating pattern across the menstrual cycle. Symptoms emerge in the final week or so before menstruation, the luteal phase, become significant in the days before the period starts, and ease within a few days after onset, followed by a stretch that's largely or completely symptom-free.

It's the cyclical timing, the severity, and the symptom-free interval that set PMDD apart. The symptoms have to be severe enough to interfere with work, school, relationships, or daily functioning. Because the timing matters so much to the diagnosis, it's ideally confirmed with prospective daily symptom tracking across at least two menstrual cycles, rather than from memory alone.

Symptoms and key features

In the days before menstruation, PMDD typically includes:

• marked irritability, anger, or increased interpersonal conflict
• depressed mood, hopelessness, or self-critical thoughts
• anxiety, tension, or a feeling of being on edge
• mood swings, with sudden tearfulness or sensitivity to rejection
• reduced interest in usual activities, difficulty concentrating, low energy
• physical symptoms such as breast tenderness, bloating, joint or muscle aches
• changes in sleep and appetite

The defining feature is the timing: these symptoms cluster in the luteal phase and lift soon after menstruation begins.

What it looks like

• For about a week each month, small frustrations feel overwhelming and conflict with people you love becomes hard to avoid.
• A low, hopeless mood arrives on a predictable schedule, then lifts within days of your period starting.
• You begin to recognize a pattern, the same difficult stretch, the same relief afterward, cycle after cycle.
• The symptom-free weeks feel like a different version of yourself, which makes the bad stretch all the more confusing.

What people often confuse this with

Ordinary PMS. Premenstrual syndrome is common and usually mild to moderate. PMDD is far more severe and, by definition, interferes with daily life. The difference is one of degree and impact, not just label.

Major depression. Depression can occur at any point in the cycle and doesn't reliably lift after menstruation. PMDD is tied to the luteal phase and includes a clear symptom-free interval. That said, depression can also worsen premenstrually, so prospective tracking helps tell them apart.

Bipolar disorder. The mood swings of PMDD follow the menstrual cycle and resolve with menstruation. Bipolar episodes follow their own course and aren't keyed to the cycle.

What research says

PMDD is well studied, and the treatment evidence is strong.

• SSRIs help. SSRIs are effective for PMDD and can be taken continuously or only during the luteal phase, an unusual and useful flexibility.
• Hormonal treatment can help. Certain hormonal contraceptives, particularly some combined formulations, can reduce symptoms for some people.
• Therapy and lifestyle measures support treatment. Cognitive behavioral therapy, along with attention to sleep, exercise, and stress, can help as part of a broader plan.
• Prevalence estimates vary. PMDD is commonly cited as affecting roughly 3 to 8 percent of menstruating people, with lower figures when stricter diagnostic criteria are applied. Any single number is best read as an estimate.

How common is it

Prevalence estimates for strict DSM-5-TR PMDD range from about 3 to 8 percent of menstruating people. Up to roughly 20 percent meet criteria for moderate to severe PMS that doesn't quite reach the PMDD threshold. PMDD usually emerges in the 20s and can persist until menopause, though its severity often shifts across the reproductive lifespan.

What causes it

The current model is that PMDD reflects an abnormal sensitivity in the central nervous system to normal hormonal fluctuations, not abnormal hormone levels. People with PMDD tend to have normal estrogen and progesterone, but they appear to be more sensitive to the cyclical shifts, particularly the late-luteal drop in allopregnanolone, a progesterone metabolite that modulates GABA signaling.

Genetic studies suggest the condition is heritable, and a family history of PMDD or major depression is common. There's no evidence that PMDD is caused by a hormone imbalance, low progesterone, or any deficiency that can be corrected with supplements.

How it's diagnosed

Diagnosis requires prospective daily symptom tracking across at least two menstrual cycles. The Daily Record of Severity of Problems (DRSP) is the standard tool. Tracking from memory is unreliable, because it tends to overestimate severity and miss the cyclical pattern that defines the disorder.

Differential diagnosis matters. Bipolar disorder, major depressive disorder with premenstrual worsening, generalized anxiety disorder, and thyroid problems all need to be considered. A condition that worsens before a period but is present throughout the cycle isn't PMDD. It's a baseline condition with cyclical worsening.

Treatment

PMDD responds well to treatment, and there's usually more than one route worth trying.

SSRIs. Selective serotonin reuptake inhibitors are first-line. Sertraline, fluoxetine, paroxetine, citalopram, and escitalopram are all options. Two dosing strategies have evidence: continuous daily dosing across the cycle, or luteal-phase-only dosing that starts at ovulation and stops at menses. Response often comes within a single cycle, which is faster than the response time for SSRIs in depression and points to a different mechanism. For detail on these medications, see PsychiatryRx.

Hormonal therapy. Combined oral contraceptives containing drospirenone in a 24/4 regimen (24 active pills, 4 placebo) are FDA-approved for PMDD. They work by suppressing ovulation and steadying the hormonal cycle. Not every formulation helps, and some can make symptoms worse, so the specific choice matters.

Other options. GnRH agonists with add-back estrogen and progesterone are used for severe, treatment-resistant cases. Spironolactone can ease physical symptoms and may have modest mood benefits.

Lifestyle. Aerobic exercise, calcium supplementation (around 1,200 mg a day), and cutting back on alcohol and caffeine in the luteal phase have small but real effects. CBT tailored for PMDD has evidence in randomized trials.

How it tends to unfold

With SSRIs, hormonal therapy, or both, most people see meaningful improvement within one to two cycles. Left untreated, PMDD often persists for years or decades. Symptoms typically resolve at menopause, when ovulation stops.